As of 2:46pm ET
| +0.18 / +7.50%|
The 4 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +113.18% increase from the last price of 2.58.
The current consensus among 5 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.